Position in CDXS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$34,668
+$9,664 QoQ
Shares Held
15,340
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 31 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Navalign, LLC holds $137,415 across 2 Biotechnology names. CDXS ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALLO |
Allogene Therapeutics, Inc.
|
49,398 | $102,747 | |
| 2 | CDXS |
Codexis, Inc.
This page
|
15,340 | $34,668 |
All Filings in CDXS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,668 | 15,340 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $25,004 | 15,340 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $25,004 | 15,340 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||